Inmunología, Oftalmología y ORL
Saila
Hospital Universitario Virgen de la Victoria
Málaga, EspañaHospital Universitario Virgen de la Victoria -ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2024
-
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Pharmacological Research, Vol. 200
2023
-
A compassion-based program to reduce psychological distress in medical students: A pilot randomized clinical trial
PloS one, Vol. 18, Núm. 6, pp. e0287388
2022
-
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Cell death & disease, Vol. 13, Núm. 2, pp. 143
-
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
Antioxidants, Vol. 11, Núm. 5
2021
-
Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
Journal of Hepatology, Vol. 75, Núm. 4, pp. 935-959
-
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Expert Opinion on Drug Metabolism and Toxicology, Vol. 17, Núm. 11, pp. 1327-1343
-
Oxidative stress in drug-induced liver injury (Dili): From mechanisms to biomarkers for use in clinical practice
Antioxidants, Vol. 10, Núm. 3, pp. 1-35
2019
-
Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury
Journal of Pathology, Vol. 247, Núm. 1, pp. 110-122
2018
-
High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries
Clinical Gastroenterology and Hepatology
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564